I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Blood Glucose
Monitoring Systems by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Blood Glucose Monitoring
Systems by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Blood Glucose Monitoring
Systems by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027

Table 4: World Current & Future Analysis for Self-Monitoring by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Self-Monitoring by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Self-Monitoring by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Continuous by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Continuous by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Continuous by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Fingertip Testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Fingertip Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Fingertip Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Alternate Site
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Alternate Site Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Alternate Site Testing
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Self / Home Care
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Self / Home Care by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Self / Home Care by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Type 1 Diabetes
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Type 1 Diabetes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Type 1 Diabetes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Type 2 Diabetes
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Type 2 Diabetes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Type 2 Diabetes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Gestational
Diabetes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Gestational Diabetes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Gestational Diabetes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 31: USA Current & Future Analysis for Blood Glucose
Monitoring Systems by Product - Self-Monitoring and Continuous -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Blood Glucose Monitoring
Systems by Product - Self-Monitoring and Continuous Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Blood Glucose Monitoring
Systems by Product - Percentage Breakdown of Value Sales for
Self-Monitoring and Continuous for the Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Blood Glucose
Monitoring Systems by Testing Site - Fingertip Testing and
Alternate Site Testing - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Blood Glucose Monitoring
Systems by Testing Site - Fingertip Testing and Alternate Site
Testing Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Blood Glucose Monitoring
Systems by Testing Site - Percentage Breakdown of Value Sales
for Fingertip Testing and Alternate Site Testing for the Years
2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Blood Glucose
Monitoring Systems by Patient Care Setting - Self / Home Care
and Hospitals & Clinics - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 38: USA Historic Review for Blood Glucose Monitoring
Systems by Patient Care Setting - Self / Home Care and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Blood Glucose Monitoring
Systems by Patient Care Setting - Percentage Breakdown of Value
Sales for Self / Home Care and Hospitals & Clinics for the
Years 2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Blood Glucose
Monitoring Systems by Application - Type 1 Diabetes, Type 2
Diabetes and Gestational Diabetes - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 41: USA Historic Review for Blood Glucose Monitoring
Systems by Application - Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Blood Glucose Monitoring
Systems by Application - Percentage Breakdown of Value Sales
for Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes
for the Years 2012, 2020 & 2027

CANADA
Table 43: Canada Current & Future Analysis for Blood Glucose
Monitoring Systems by Product - Self-Monitoring and Continuous -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 44: Canada Historic Review for Blood Glucose Monitoring
Systems by Product - Self-Monitoring and Continuous Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Blood Glucose
Monitoring Systems by Product - Percentage Breakdown of Value
Sales for Self-Monitoring and Continuous for the Years 2012,
2020 & 2027

Table 46: Canada Current & Future Analysis for Blood Glucose
Monitoring Systems by Testing Site - Fingertip Testing and
Alternate Site Testing - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Blood Glucose Monitoring
Systems by Testing Site - Fingertip Testing and Alternate Site
Testing Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Blood Glucose
Monitoring Systems by Testing Site - Percentage Breakdown of
Value Sales for Fingertip Testing and Alternate Site Testing
for the Years 2012, 2020 & 2027

Table 49: Canada Current & Future Analysis for Blood Glucose
Monitoring Systems by Patient Care Setting - Self / Home Care
and Hospitals & Clinics - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 50: Canada Historic Review for Blood Glucose Monitoring
Systems by Patient Care Setting - Self / Home Care and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Blood Glucose
Monitoring Systems by Patient Care Setting - Percentage
Breakdown of Value Sales for Self / Home Care and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 52: Canada Current & Future Analysis for Blood Glucose
Monitoring Systems by Application - Type 1 Diabetes, Type 2
Diabetes and Gestational Diabetes - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 53: Canada Historic Review for Blood Glucose Monitoring
Systems by Application - Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 54: Canada 15-Year Perspective for Blood Glucose
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes for the Years 2012, 2020 & 2027

JAPAN
Table 55: Japan Current & Future Analysis for Blood Glucose
Monitoring Systems by Product - Self-Monitoring and Continuous -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Blood Glucose Monitoring
Systems by Product - Self-Monitoring and Continuous Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Blood Glucose
Monitoring Systems by Product - Percentage Breakdown of Value
Sales for Self-Monitoring and Continuous for the Years 2012,
2020 & 2027

Table 58: Japan Current & Future Analysis for Blood Glucose
Monitoring Systems by Testing Site - Fingertip Testing and
Alternate Site Testing - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 59: Japan Historic Review for Blood Glucose Monitoring
Systems by Testing Site - Fingertip Testing and Alternate Site
Testing Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for Blood Glucose
Monitoring Systems by Testing Site - Percentage Breakdown of
Value Sales for Fingertip Testing and Alternate Site Testing
for the Years 2012, 2020 & 2027

Table 61: Japan Current & Future Analysis for Blood Glucose
Monitoring Systems by Patient Care Setting - Self / Home Care
and Hospitals & Clinics - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 62: Japan Historic Review for Blood Glucose Monitoring
Systems by Patient Care Setting - Self / Home Care and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 63: Japan 15-Year Perspective for Blood Glucose
Monitoring Systems by Patient Care Setting - Percentage
Breakdown of Value Sales for Self / Home Care and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 64: Japan Current & Future Analysis for Blood Glucose
Monitoring Systems by Application - Type 1 Diabetes, Type 2
Diabetes and Gestational Diabetes - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 65: Japan Historic Review for Blood Glucose Monitoring
Systems by Application - Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 66: Japan 15-Year Perspective for Blood Glucose
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes for the Years 2012, 2020 & 2027

CHINA
Table 67: China Current & Future Analysis for Blood Glucose
Monitoring Systems by Product - Self-Monitoring and Continuous -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 68: China Historic Review for Blood Glucose Monitoring
Systems by Product - Self-Monitoring and Continuous Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for Blood Glucose
Monitoring Systems by Product - Percentage Breakdown of Value
Sales for Self-Monitoring and Continuous for the Years 2012,
2020 & 2027

Table 70: China Current & Future Analysis for Blood Glucose
Monitoring Systems by Testing Site - Fingertip Testing and
Alternate Site Testing - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 71: China Historic Review for Blood Glucose Monitoring
Systems by Testing Site - Fingertip Testing and Alternate Site
Testing Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 72: China 15-Year Perspective for Blood Glucose
Monitoring Systems by Testing Site - Percentage Breakdown of
Value Sales for Fingertip Testing and Alternate Site Testing
for the Years 2012, 2020 & 2027

Table 73: China Current & Future Analysis for Blood Glucose
Monitoring Systems by Patient Care Setting - Self / Home Care
and Hospitals & Clinics - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 74: China Historic Review for Blood Glucose Monitoring
Systems by Patient Care Setting - Self / Home Care and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 75: China 15-Year Perspective for Blood Glucose
Monitoring Systems by Patient Care Setting - Percentage
Breakdown of Value Sales for Self / Home Care and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 76: China Current & Future Analysis for Blood Glucose
Monitoring Systems by Application - Type 1 Diabetes, Type 2
Diabetes and Gestational Diabetes - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 77: China Historic Review for Blood Glucose Monitoring
Systems by Application - Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 78: China 15-Year Perspective for Blood Glucose
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes for the Years 2012, 2020 & 2027

EUROPE
Table 79: Europe Current & Future Analysis for Blood Glucose
Monitoring Systems by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 80: Europe Historic Review for Blood Glucose Monitoring
Systems by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 81: Europe 15-Year Perspective for Blood Glucose
Monitoring Systems by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2012, 2020 & 2027

Table 82: Europe Current & Future Analysis for Blood Glucose
Monitoring Systems by Product - Self-Monitoring and Continuous -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 83: Europe Historic Review for Blood Glucose Monitoring
Systems by Product - Self-Monitoring and Continuous Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 84: Europe 15-Year Perspective for Blood Glucose
Monitoring Systems by Product - Percentage Breakdown of Value
Sales for Self-Monitoring and Continuous for the Years 2012,
2020 & 2027

Table 85: Europe Current & Future Analysis for Blood Glucose
Monitoring Systems by Testing Site - Fingertip Testing and
Alternate Site Testing - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 86: Europe Historic Review for Blood Glucose Monitoring
Systems by Testing Site - Fingertip Testing and Alternate Site
Testing Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 87: Europe 15-Year Perspective for Blood Glucose
Monitoring Systems by Testing Site - Percentage Breakdown of
Value Sales for Fingertip Testing and Alternate Site Testing
for the Years 2012, 2020 & 2027

Table 88: Europe Current & Future Analysis for Blood Glucose
Monitoring Systems by Patient Care Setting - Self / Home Care
and Hospitals & Clinics - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 89: Europe Historic Review for Blood Glucose Monitoring
Systems by Patient Care Setting - Self / Home Care and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 90: Europe 15-Year Perspective for Blood Glucose
Monitoring Systems by Patient Care Setting - Percentage
Breakdown of Value Sales for Self / Home Care and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 91: Europe Current & Future Analysis for Blood Glucose
Monitoring Systems by Application - Type 1 Diabetes, Type 2
Diabetes and Gestational Diabetes - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 92: Europe Historic Review for Blood Glucose Monitoring
Systems by Application - Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 93: Europe 15-Year Perspective for Blood Glucose
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes for the Years 2012, 2020 & 2027

FRANCE
Table 94: France Current & Future Analysis for Blood Glucose
Monitoring Systems by Product - Self-Monitoring and Continuous -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 95: France Historic Review for Blood Glucose Monitoring
Systems by Product - Self-Monitoring and Continuous Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 96: France 15-Year Perspective for Blood Glucose
Monitoring Systems by Product - Percentage Breakdown of Value
Sales for Self-Monitoring and Continuous for the Years 2012,
2020 & 2027

Table 97: France Current & Future Analysis for Blood Glucose
Monitoring Systems by Testing Site - Fingertip Testing and
Alternate Site Testing - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 98: France Historic Review for Blood Glucose Monitoring
Systems by Testing Site - Fingertip Testing and Alternate Site
Testing Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 99: France 15-Year Perspective for Blood Glucose
Monitoring Systems by Testing Site - Percentage Breakdown of
Value Sales for Fingertip Testing and Alternate Site Testing
for the Years 2012, 2020 & 2027

Table 100: France Current & Future Analysis for Blood Glucose
Monitoring Systems by Patient Care Setting - Self / Home Care
and Hospitals & Clinics - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 101: France Historic Review for Blood Glucose Monitoring
Systems by Patient Care Setting - Self / Home Care and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 102: France 15-Year Perspective for Blood Glucose
Monitoring Systems by Patient Care Setting - Percentage
Breakdown of Value Sales for Self / Home Care and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 103: France Current & Future Analysis for Blood Glucose
Monitoring Systems by Application - Type 1 Diabetes, Type 2
Diabetes and Gestational Diabetes - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 104: France Historic Review for Blood Glucose Monitoring
Systems by Application - Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 105: France 15-Year Perspective for Blood Glucose
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes for the Years 2012, 2020 & 2027

GERMANY
Table 106: Germany Current & Future Analysis for Blood Glucose
Monitoring Systems by Product - Self-Monitoring and Continuous -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 107: Germany Historic Review for Blood Glucose Monitoring
Systems by Product - Self-Monitoring and Continuous Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 108: Germany 15-Year Perspective for Blood Glucose
Monitoring Systems by Product - Percentage Breakdown of Value
Sales for Self-Monitoring and Continuous for the Years 2012,
2020 & 2027

Table 109: Germany Current & Future Analysis for Blood Glucose
Monitoring Systems by Testing Site - Fingertip Testing and
Alternate Site Testing - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 110: Germany Historic Review for Blood Glucose Monitoring
Systems by Testing Site - Fingertip Testing and Alternate Site
Testing Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 111: Germany 15-Year Perspective for Blood Glucose
Monitoring Systems by Testing Site - Percentage Breakdown of
Value Sales for Fingertip Testing and Alternate Site Testing
for the Years 2012, 2020 & 2027

Table 112: Germany Current & Future Analysis for Blood Glucose
Monitoring Systems by Patient Care Setting - Self / Home Care
and Hospitals & Clinics - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 113: Germany Historic Review for Blood Glucose Monitoring
Systems by Patient Care Setting - Self / Home Care and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 114: Germany 15-Year Perspective for Blood Glucose
Monitoring Systems by Patient Care Setting - Percentage
Breakdown of Value Sales for Self / Home Care and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 115: Germany Current & Future Analysis for Blood Glucose
Monitoring Systems by Application - Type 1 Diabetes, Type 2
Diabetes and Gestational Diabetes - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 116: Germany Historic Review for Blood Glucose Monitoring
Systems by Application - Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 117: Germany 15-Year Perspective for Blood Glucose
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes for the Years 2012, 2020 & 2027

ITALY
Table 118: Italy Current & Future Analysis for Blood Glucose
Monitoring Systems by Product - Self-Monitoring and Continuous -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 119: Italy Historic Review for Blood Glucose Monitoring
Systems by Product - Self-Monitoring and Continuous Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 120: Italy 15-Year Perspective for Blood Glucose
Monitoring Systems by Product - Percentage Breakdown of Value
Sales for Self-Monitoring and Continuous for the Years 2012,
2020 & 2027

Table 121: Italy Current & Future Analysis for Blood Glucose
Monitoring Systems by Testing Site - Fingertip Testing and
Alternate Site Testing - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 122: Italy Historic Review for Blood Glucose Monitoring
Systems by Testing Site - Fingertip Testing and Alternate Site
Testing Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 123: Italy 15-Year Perspective for Blood Glucose
Monitoring Systems by Testing Site - Percentage Breakdown of
Value Sales for Fingertip Testing and Alternate Site Testing
for the Years 2012, 2020 & 2027

Table 124: Italy Current & Future Analysis for Blood Glucose
Monitoring Systems by Patient Care Setting - Self / Home Care
and Hospitals & Clinics - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 125: Italy Historic Review for Blood Glucose Monitoring
Systems by Patient Care Setting - Self / Home Care and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 126: Italy 15-Year Perspective for Blood Glucose
Monitoring Systems by Patient Care Setting - Percentage
Breakdown of Value Sales for Self / Home Care and Hospitals &
Clinics for the Years 2012, 2020 & 2027

Table 127: Italy Current & Future Analysis for Blood Glucose
Monitoring Systems by Application - Type 1 Diabetes, Type 2
Diabetes and Gestational Diabetes - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 128: Italy Historic Review for Blood Glucose Monitoring
Systems by Application - Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 129: Italy 15-Year Perspective for Blood Glucose
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Type 1 Diabetes, Type 2 Diabetes and
Gestational Diabetes for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 130: UK Current & Future Analysis for Blood Glucose
Monitoring Systems by Product - Self-Monitoring and Continuous -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 131: UK Historic Review for Blood Glucose Monitoring
Systems by Product - Self-Monitoring and Continuous Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 132: UK 15-Year Perspective for Blood Glucose Monitoring
Systems by Product - Percentage Breakdown of Value Sales for
Self-Monitoring and Continuous for the Years 2012, 2020 & 2027

Table 133: UK Current & Future Analysis for Blood Glucose
Monitoring Systems by Testing Site - Fingertip Testing and
Alternate Site Testing - Independent Analysis of Annual Sales

Please contact our Customer Support Center to get the complete Table of Contents